Open access
Open access
Powered by Google Translator Translator

Covid-19

One third of patients hospitalized with COVID-19 have lung changes after a year

7 May, 2021 | 08:37h | UTC

3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study – The Lancet Respiratory Medicine

Commentaries: One third of patients hospitalized with COVID-19 have lung changes after a year – University of Southampton AND An integrated understanding of long-term sequelae after acute COVID-19 – The Lancet Respiratory Medicine

 


COVID-19 has caused 6.9 million deaths globally, more than double what official reports show

7 May, 2021 | 08:35h | UTC

News release: COVID-19 has caused 6.9 million deaths globally, more than double what official reports show – Institute for Health Metrics and Evaluation

Report: Estimation of total mortality due to COVID-19 – Institute for Health Metrics and Evaluation

Commentaries: New analysis finds global Covid death toll is double official estimates – STAT AND Global COVID-19 death toll more than double official estimates – IHME – Reuters

 


Cohort study: Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S. 11 excess venous thromboembolic events per 100 000 vaccinations; 2.5 excess cerebral venous thrombosis per 100 000 vaccinations.

7 May, 2021 | 08:33h | UTC

Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study – The BMJ

Editorial: Thromboembolism and the Oxford-AstraZeneca vaccine – The BMJ

Commentaries: Thrombosis and bleeding after the Oxford-AstraZeneca covid-19 vaccination – The BMJ Opinion AND Putting risks into context: covid-19 vaccines and blood clots – The BMJ Opinion AND Expert reaction to study from Denmark and Norway looking at rare blood clots after the Oxford-AstraZeneca vaccine – Science Media Centre

 

Commentary on Twitter

 


Opinion | Covid-19: Sputnik vaccine rockets, thanks to Lancet boost

7 May, 2021 | 08:31h | UTC

Covid-19: Sputnik vaccine rockets, thanks to Lancet boost – The BMJ

 

Commentary on Twitter

 


The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity

7 May, 2021 | 08:30h | UTC

The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity – The Lancet Respiratory Medicine

 

Commentary on Twitter

 


In shock move, US backs waiving patents on COVID vaccines. “The development from the Biden administration draws cheers from public health researchers and ire from drugmakers.”

6 May, 2021 | 09:10h | UTC

In shock move, US backs waiving patents on COVID vaccines – Nature

See also: U.S. will back proposal to waive intellectual property rights and boost Covid-19 vaccine production – STAT AND Statement from the Executive Director of UNAIDS, Winnie Byanyima on the decision by the United States of America to support the TRIPS waiver for COVID-19 vaccines – UNAIDS AND WHO Director-General commends United States decision to support temporary waiver on intellectual property rights for COVID-19 vaccines – World Health Organization

 

Commentary on Twitter

 


RCT: Novavax vaccine is 49.4% effective against B.1.351 SARS-CoV-2 variant.

6 May, 2021 | 09:08h | UTC

Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant – New England Journal of Medicine

 


Observational study in Qatar: Pfizer–BioNTech Covid vaccine is 89.5% effective against B.1.1.7 variant and 75.0% effective against B.1.351 variant. Vaccine effectiveness against severe, critical, or fatal disease with any SARS-CoV-2 variant was very high, at 97.4%.

6 May, 2021 | 09:06h | UTC

Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants – New England Journal of Medicine

Commentary: Pfizer-BioNTech vaccine offers strong protection against key variants of concern, real-world data from Qatar shows – The Washington Post

 

Commentary on Twitter

 


Observational study in Israel: Pfizer-BioNTech is 95.3% effective against SARS-CoV-2 infection.

6 May, 2021 | 09:04h | UTC

Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data – The Lancet

Commentaries: Expert reaction to Israel nation-wide study looking at Pfizer vaccine effectiveness – Science Media Centre AND Covid-19: Two doses of Pfizer vaccine are “highly effective” against infection, hospital admission, and death, study finds – The BMJ

 


Organ transplant recipients remain vulnerable to Covid-19 even after second vaccine dose.

6 May, 2021 | 09:03h | UTC

Organ Transplant Recipients Remain Vulnerable to Covid-19 Even After Second Vaccine Dose – Johns Hopkins Medicine

Original Study: Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients – JAMA

 


Cohort study shows inadequate antibody response to mRNA SARS-CoV-2 vaccine among kidney transplant recipients.

6 May, 2021 | 09:01h | UTC

Antibody response to mRNA SARS-CoV-2 vaccine among kidney transplant recipients – Prospective cohort study – Clinical Microbiology and Infection

 

Commentary on Twitter

 


Perspective | How many COVID deaths are acceptable in a post-pandemic world? “Even after mass vaccinations, some hospitalizations and deaths from the coronavirus are inevitable — but opinions differ on how many is too many for a return to relative normality.”

6 May, 2021 | 08:59h | UTC

How many COVID deaths are acceptable in a post-pandemic world? – Nature

 


[Press release – not published yet] Moderna announces positive initial booster data against SARS-CoV-2 variants of concern.

6 May, 2021 | 08:57h | UTC

Moderna Announces Positive Initial Booster Data Against SARS-CoV-2 Variants of Concern – Moderna

Commentary: We just got our first evidence that Moderna’s coronavirus booster shot works to fight variants – Insider

 

Commentaries on Twitter

 


[Preprint] SARS-CoV-2 antibodies remain detectable 12 months after infection and antibody magnitude is associated with age and COVID-19 severity

5 May, 2021 | 08:40h | UTC

SARS-CoV-2 antibodies remain detectable 12 months after infection and antibody magnitude is associated with age and COVID-19 severity – medRxiv

Commentary: SARS-CoV-2 antibodies are detectable up to a year after infection, finds study – News Medical

 

Commentary on Twitter

 


COVID has pushed medical research into remote trials, benefiting patients and scientists

5 May, 2021 | 08:38h | UTC

COVID Has Pushed Medical Research into Remote Trials, Benefiting Patients and Scientists – Scientific American

 


What’s the future of vaccines linked to rare clotting disorders? Science breaks down the latest

5 May, 2021 | 08:37h | UTC

What’s the future of vaccines linked to rare clotting disorders? Science breaks down the latest – Science

 


Covax: How will Covid vaccines be shared around the world?

5 May, 2021 | 08:35h | UTC

Covax: How will Covid vaccines be shared around the world? – BBC

Related: WHO chief – The world can bring the global COVID-19 pandemic under control in the coming months provided it distributes the necessary resources fairly AND A year in the COVID-19 vaccine scheme COVAX

 


Perspective | We may never achieve long-term global herd immunity for COVID. But if we’re all vaccinated, we’ll be safe from the worst

5 May, 2021 | 08:33h | UTC

We may never achieve long-term global herd immunity for COVID. But if we’re all vaccinated, we’ll be safe from the worst – The Conversation

See also: Reaching ‘Herd Immunity’ Is Unlikely in the U.S., Experts Now Believe – The New York Times (free registration required) AND We May Never Get to Herd Immunity – Think Global Health

 


China’s COVID vaccines are going global — but questions remain

5 May, 2021 | 08:32h | UTC

China’s COVID vaccines are going global — but questions remain – Nature

 


M-A: Prone positioning of nonintubated patients with Covid-19 improve oxygenation variables without any reported serious adverse events – randomized trials with patient-relevant outcomes such as the need for intubation or mortality rates are required

4 May, 2021 | 08:52h | UTC

Prone Positioning of Nonintubated Patients With Coronavirus Disease 2019—A Systematic Review and Meta-Analysis – Critical Care Medicine (link to abstract – $ for full-text)

 


Prior SARS-CoV-2 infection boosts response to variants after first vaccine dose

4 May, 2021 | 08:51h | UTC

Prior SARS-CoV-2 infection boosts response to variants after first vaccine dose – Imperial College London

Original study: Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose – Science

 

Commentary on Twitter (thread – click for more)

 


WHO lists Moderna vaccine for emergency use

4 May, 2021 | 08:49h | UTC

WHO lists Moderna vaccine for emergency use – World Health Organization

 


WHO Inches Closer to Approval of Chinese Sinopharm and Sinovac Vaccines

4 May, 2021 | 08:49h | UTC

WHO Inches Closer to Approval of Chinese Sinopharm and Sinovac Vaccines – Health Policy Watch

 


COVID studies note online learning stress, fewer cases in schools with protocols

4 May, 2021 | 08:47h | UTC

COVID studies note online learning stress, fewer cases in schools with protocols – CIDRAP

Study 1: COVID-19 Infections Among Students and Staff in New York City Public Schools – Pediatrics

Study 2:  Household COVID-19 risk and in-person schooling – Science

Study 3: Caregiver Perceptions of Children’s Psychological Well-being During the COVID-19 Pandemic – JAMA Network Open AND Editorial: It Is Time to End the Debate Over School Reopening

 


Novel coronavirus really is seasonal, study suggests

4 May, 2021 | 08:46h | UTC

Novel coronavirus really is seasonal, study suggests – LiveScience

Original study: Climate and the spread of COVID-19 – Scientific Reports

 


Stay Updated in Your Specialty

No spam, just news.